GlaxoSmithKline update: A (H1N1) influenza vaccine development
GSK has received orders from several governments aiming to stockpile a H1N1 adjuvanted influenza vaccine as a precautionary measure.
Read the full articleYou might also wanna read

Commission seeks feedback on commitments offered by Sanofi over possible anticompetitive conduct regarding the promotion of a flu vaccine for vulnerable patients
The European Commission invites comments on commitments offered by Sanofi to address competition concerns regarding a communication campaign

Commission opens investigation into possible anticompetitive conduct by Sanofi regarding the promotion of a flu vaccine for vulnerable patients
Commission opens investigation into possible anticompetitive conduct by Sanofi regarding the promotion of a flu vaccine for vulnerable patie
Sanofi to Stop Disparaging Rival Flu Vaccine to Stave Off EU Antitrust Fine
French pharmaceutical company Sanofi has offered to state publicly that a rival flu vaccine is as effective as its own, EU antitrust regula
FDA advisory panel recommends updating fall Covid vaccines to target XFG variant
The advisory panel recommended updating this fall’s Covid shots to target the XFG variant, a fast-growing strain nicknamed “stratus.”

Bird flu vaccine trial against potential pandemic strain begins
The jab targets the H5N1 flu strain which has caused devastating infections in bird populations worldwide, but has yet to spread between hum
CDC Releases 2015 2016 Flu Shot Recommendations
CDC announced some people should get their flu vaccination before the end of December.

Comments
Sign in to join the conversation.
No comments yet. Be the first.